Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19

Detalles Bibliográficos
Autores principales: Supady, Alexander, Duerschmied, Daniel, Bode, Christoph, Rieder, Marina, Lother, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439244/
https://www.ncbi.nlm.nih.gov/pubmed/32819415
http://dx.doi.org/10.1186/s13054-020-03238-1
_version_ 1783572941157433344
author Supady, Alexander
Duerschmied, Daniel
Bode, Christoph
Rieder, Marina
Lother, Achim
author_facet Supady, Alexander
Duerschmied, Daniel
Bode, Christoph
Rieder, Marina
Lother, Achim
author_sort Supady, Alexander
collection PubMed
description
format Online
Article
Text
id pubmed-7439244
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74392442020-08-20 Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19 Supady, Alexander Duerschmied, Daniel Bode, Christoph Rieder, Marina Lother, Achim Crit Care Letter BioMed Central 2020-08-20 /pmc/articles/PMC7439244/ /pubmed/32819415 http://dx.doi.org/10.1186/s13054-020-03238-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter
Supady, Alexander
Duerschmied, Daniel
Bode, Christoph
Rieder, Marina
Lother, Achim
Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
title Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
title_full Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
title_fullStr Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
title_full_unstemmed Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
title_short Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
title_sort extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of il-6 in covid-19
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439244/
https://www.ncbi.nlm.nih.gov/pubmed/32819415
http://dx.doi.org/10.1186/s13054-020-03238-1
work_keys_str_mv AT supadyalexander extracorporealcytokineadsorptionasanalternativetopharmacologicalinhibitionofil6incovid19
AT duerschmieddaniel extracorporealcytokineadsorptionasanalternativetopharmacologicalinhibitionofil6incovid19
AT bodechristoph extracorporealcytokineadsorptionasanalternativetopharmacologicalinhibitionofil6incovid19
AT riedermarina extracorporealcytokineadsorptionasanalternativetopharmacologicalinhibitionofil6incovid19
AT lotherachim extracorporealcytokineadsorptionasanalternativetopharmacologicalinhibitionofil6incovid19

Ejemplares similares